The European Commission announced on Thursday 17 December that it has concluded preliminary discussions with the US pharmaceutical company Novavax to purchase 100 million doses of its Covid-19 vaccine (see EUROPE B12592A1). The discussions also covered the possibility of an additional 100 million doses, if required.
It should be noted that the European Union has already held preliminary discussions and concluded advance purchase agreements with six pharmaceutical companies, namely...